Press Release Details
India Business Seminar: Getting to know Brand India Pharma better
October 23, 2013, Frankfurt:
Pharmexcil and IBEF organised a business seminar - Getting to know Brand India Pharma better on the second day of CPhI Worldwide 2013, which was well attended.
India is a producer of high-quality affordable medicines and a leading supplier to both developed and developing nations across the globe,said Mr Sudhanshu Pandey, Joint Secretary, Department of Commerce, Government of India.
Dr Yusuf K Hamied, Chairman, Cipla, and Dr Appaji, Director General, Pharmexcil, spoke of the phenomenal journey of Indian pharma industry over the past six decades.
Interesting facts on the successes and achievements of the Indian pharma industry were an eye opener for some at the seminar - Eight out of top 25 generic companies across the world are from India; every third tablet produced in the world is made in India; every third child in the world is getting Indian vaccines; India has the highest number of USFDA facilities outside US and many more. Presentations in this context by the Vice Chairman of Pharmaceutical Export Promotion Council of India (Pharmexcil), Mr Ashutosh Gupta and Dr S E Reddy, Deputy Drugs Controller General of India, Central Drugs Standard Control Organization, Government of India, were highly informative.
The seminar also included a panel discussion on how Indian companies were striving to serve the global pharma needs. Leading industry veterans from India, namely, Dr Ajit Singh, Chairman, ACG Worldwide, Dr MSN Reddy, Chairman and Managing Director, MSN Laboratories, Dr B L Meena, Director General, Drugs Control Administration, Government of Andhra Pradesh and Mr Arvind Vasudeva, Chief Executive Officer (Formulations), Aurobindo Pharma, were a part of the panel discussion.
The India pharma industry reiterated that it was confident of surpassing the US$ 25 billion pharma export target set by the Government of India by 2016.